As Recipharm continues to refine its footprint, the CDMO is selling its development and small-scale active pharmaceutical ingredient (API) manufacturing facility in Yavne, Israel, to Scinai ...

Frost & Sullivan is pleased to announce that Bioiberica has received the 2025 European New Product Innovation Recognition in the ...

The company said Tuesday that the FDA greenlit a supplemental new drug application for Wakix, a treatment for cataplexy, a narcolepsy symptom characterized by sudden muscle weakness, in pediatric ...

Kalyan: The Manpada police have busted a major counterfeit medicine racket involving fake supplies of Telma AM, a widely ...

Ocular Therapeutix reported a phase 3 win that it believes can validate its attempts to challenge Regeneron’s entrenched ...

DFE Pharma has launched its Continuous Manufacturing (CM) platform, designed to support pharmaceutical companies in ...

The pharmaceutical manufacturing market is poised for growth by leveraging advanced technologies, digital platforms, and robust supply chain strategies. Opportunities arise in adopting ...

Ipca remains on a robust growth path in domestic formulation segment, as the company not only delivered healthy double-digit ...

India, Feb. 16 -- A pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services has come into the spotlight after ...

Ipca Laboratories Ltd (BOM:524494) reports robust domestic and export growth, with significant improvements in EBITDA margins despite challenges in certain segments.

The pharmaceutical sector continues to witness earnings-driven momentum as companies report resilient Q3 FY26 performance, supported by strong domestic demand, export traction, and improved ...

Welcome to the PharmTech Weekly Roundup, your briefing on the latest developments in pharmaceutical manufacturing and development for the week of February 9, 2026. I’m your host, associate editorial ...